Stricture Definition and Treatment (STRIDENT) Drug Therapy Study
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 09 Dec 2019
Price : $35 *
At a glance
- Drugs Adalimumab (Primary) ; Purines
- Indications Crohn's disease
- Focus Therapeutic Use
- Acronyms STRIDENT
- 04 Dec 2019 Status changed from recruiting to active, no longer recruiting.
- 29 Aug 2019 Planned End Date changed from 1 Sep 2019 to 1 Sep 2020.
- 29 Aug 2019 Planned primary completion date changed from 1 Jul 2019 to 1 Sep 2020.